Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,130.00
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.37
(
-0.28%
)
Bitcoin
74,150.14
(
0.28%
)
News Focus
News Focus

Replies to post #133794 on Biotech Values

Replies to #133794 on Biotech Values
icon url

DewDiligence

12/24/11 4:33 PM

#133798 RE: Regulardoc #133794

Who pays for the costs of clinical trials for the first two compounds?

BAX does. For the first two FoB’s in the collaboration, MNTA pays for pre-IND process development and is reimbursed by BAX via the $91M in technical/development milestones (#msg-70258421, #msg-70234186). After the IND filing for each of the first two compounds, BAX bears all of the development and commercialization costs.